Literature DB >> 35453080

Multi-omic approach to identify risk markers specific to COVID-19.

Won-Young Kim1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35453080      PMCID: PMC9017394          DOI: 10.1016/j.ebiom.2022.104009

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   11.205


× No keyword cloud information.
  9 in total

1.  Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.

Authors:  Eline L Vegter; Daniela Schmitter; Yanick Hagemeijer; Ekaterina S Ovchinnikova; Pim van der Harst; John R Teerlink; Christopher M O'Connor; Marco Metra; Beth A Davison; Daniel Bloomfield; Gad Cotter; John G Cleland; Michael M Givertz; Piotr Ponikowski; Dirk J van Veldhuisen; Peter van der Meer; Eugene Berezikov; Adriaan A Voors; Mohsin A F Khan
Journal:  Int J Cardiol       Date:  2016-09-11       Impact factor: 4.164

Review 2.  Acute respiratory distress syndrome.

Authors:  Michael A Matthay; Rachel L Zemans; Guy A Zimmerman; Yaseen M Arabi; Jeremy R Beitler; Alain Mercat; Margaret Herridge; Adrienne G Randolph; Carolyn S Calfee
Journal:  Nat Rev Dis Primers       Date:  2019-03-14       Impact factor: 52.329

3.  Understanding pathways to death in patients with COVID-19.

Authors:  Jean-Louis Vincent; Fabio S Taccone
Journal:  Lancet Respir Med       Date:  2020-04-06       Impact factor: 30.700

4.  COVID-19: the vasculature unleashed.

Authors:  Laure-Anne Teuwen; Vincent Geldhof; Alessandra Pasut; Peter Carmeliet
Journal:  Nat Rev Immunol       Date:  2020-07       Impact factor: 53.106

5.  Efficacy of synthetic glucocorticoids in COVID-19 endothelites.

Authors:  Francesco Ferrara; Antonio Vitiello
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-14       Impact factor: 3.000

6.  Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies.

Authors:  Dakota Gustafson; Michelle Ngai; Ruilin Wu; Huayun Hou; Alice Carvalhal Schoffel; Clara Erice; Serena Mandla; Filio Billia; Michael D Wilson; Milica Radisic; Eddy Fan; Uriel Trahtemberg; Andrew Baker; Chris McIntosh; Chun-Po S Fan; Claudia C Dos Santos; Kevin C Kain; Kate Hanneman; Paaladinesh Thavendiranathan; Jason E Fish; Kathryn L Howe
Journal:  EBioMedicine       Date:  2022-04-08       Impact factor: 11.205

7.  Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.

Authors:  Won-Young Kim; Oh Joo Kweon; Min Jae Cha; Moon Seong Baek; Seong-Ho Choi
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

8.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.